JP2010521451A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010521451A5 JP2010521451A5 JP2009553263A JP2009553263A JP2010521451A5 JP 2010521451 A5 JP2010521451 A5 JP 2010521451A5 JP 2009553263 A JP2009553263 A JP 2009553263A JP 2009553263 A JP2009553263 A JP 2009553263A JP 2010521451 A5 JP2010521451 A5 JP 2010521451A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pyrazolo
- oxa
- azaspiro
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 515
- -1 1-oxa-2-azaspiro [4.4] non-2-en-3-yl Chemical group 0.000 claims 89
- 125000004938 5-pyridyl group Chemical group N1=CC=CC(=C1)* 0.000 claims 43
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 35
- 125000000217 alkyl group Chemical group 0.000 claims 24
- NZNMSOFKMUBTKW-UHFFFAOYSA-N Cyclohexanecarboxylic acid Natural products OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 claims 20
- 238000000034 method Methods 0.000 claims 17
- 238000004519 manufacturing process Methods 0.000 claims 15
- 229910052736 halogen Inorganic materials 0.000 claims 14
- 125000005843 halogen group Chemical group 0.000 claims 13
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 12
- VZFUCHSFHOYXIS-UHFFFAOYSA-N cycloheptane carboxylic acid Natural products OC(=O)C1CCCCCC1 VZFUCHSFHOYXIS-UHFFFAOYSA-N 0.000 claims 12
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 claims 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims 11
- 229960004979 fampridine Drugs 0.000 claims 11
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims 10
- 230000003301 hydrolyzing effect Effects 0.000 claims 8
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 7
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 125000006239 protecting group Chemical group 0.000 claims 6
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 3
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexyloxide Natural products O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 claims 3
- 230000001590 oxidative effect Effects 0.000 claims 3
- 229910052698 phosphorus Inorganic materials 0.000 claims 3
- 239000011574 phosphorus Substances 0.000 claims 3
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims 3
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- DEEWYTJMOOJNBK-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(2h-tetrazol-5-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=NN=NN1 DEEWYTJMOOJNBK-UHFFFAOYSA-N 0.000 claims 2
- ZNFZKLZYIWAINB-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(2h-tetrazol-5-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC=1N=NNN=1 ZNFZKLZYIWAINB-UHFFFAOYSA-N 0.000 claims 2
- MLKUXEUXLXZRIW-UHFFFAOYSA-N 1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(2h-tetrazol-5-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=NN=NN1 MLKUXEUXLXZRIW-UHFFFAOYSA-N 0.000 claims 2
- WMLAXUQNIMKNOY-UHFFFAOYSA-N 1-ethyl-n-(oxan-4-yl)-5-[8-(2h-tetrazol-5-yl)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC(CC2)C=2NN=NN=2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 WMLAXUQNIMKNOY-UHFFFAOYSA-N 0.000 claims 2
- JEQLNHRWXLRVHS-UHFFFAOYSA-N 1-oxa-7-azaspiro[3.4]oct-6-ene-2-carboxylic acid Chemical compound O1C(C(=O)O)CC11CN=CC1 JEQLNHRWXLRVHS-UHFFFAOYSA-N 0.000 claims 2
- JFNPQHWGYOMASF-UHFFFAOYSA-N 2-methyloct-6-enamide Chemical compound CC(CCCC=CC)C(=O)N JFNPQHWGYOMASF-UHFFFAOYSA-N 0.000 claims 2
- PZFJUACXAVTYCR-UHFFFAOYSA-N 3-[1-ethyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-ol Chemical compound N=1OC2(CCC(O)CC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 PZFJUACXAVTYCR-UHFFFAOYSA-N 0.000 claims 2
- YQHLBGCEOFVNRI-UHFFFAOYSA-N 3-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-ol Chemical compound N=1OC2(CCC(O)CC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 YQHLBGCEOFVNRI-UHFFFAOYSA-N 0.000 claims 2
- GNWLJMQPQWNRAW-UHFFFAOYSA-N 3-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide Chemical compound N=1OC2(CCC(CC2)C(N)=O)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 GNWLJMQPQWNRAW-UHFFFAOYSA-N 0.000 claims 2
- LFFBLXGLSVUNCU-UHFFFAOYSA-N 3-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid Chemical compound N=1OC2(CCC(CC2)C(O)=O)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 LFFBLXGLSVUNCU-UHFFFAOYSA-N 0.000 claims 2
- DQXSINZAPNJLPW-UHFFFAOYSA-N 7-[1-ethyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-ol Chemical compound N=1OC2(CC(O)C2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 DQXSINZAPNJLPW-UHFFFAOYSA-N 0.000 claims 2
- FVOWSQAKARXCSJ-UHFFFAOYSA-N 7-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide Chemical compound N=1OC2(CC(C2)C(N)=O)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 FVOWSQAKARXCSJ-UHFFFAOYSA-N 0.000 claims 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- TXWOGHSRPAYOML-UHFFFAOYSA-N cyclobutanecarboxylic acid Chemical compound OC(=O)C1CCC1 TXWOGHSRPAYOML-UHFFFAOYSA-N 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- ZIQKZQQAOSZFCA-UHFFFAOYSA-N n-cyclohexyl-1-ethyl-5-[2-(2h-tetrazol-5-yl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CC(C2)C=2NN=NN=2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 ZIQKZQQAOSZFCA-UHFFFAOYSA-N 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- PZHUBHQXCJHHLB-UHFFFAOYSA-N 1-(cyclopropylmethyl)-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N1=CC2=C(NC3CCOCC3)C(C=3CC4(CCCC4)ON=3)=CN=C2N1CC1CC1 PZHUBHQXCJHHLB-UHFFFAOYSA-N 0.000 claims 1
- SBGGPVSBKJWNLG-UHFFFAOYSA-N 1-(cyclopropylmethyl)-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N1=CC2=C(NC3CCOCC3)C(C=3CC4(ON=3)CCCCC4)=CN=C2N1CC1CC1 SBGGPVSBKJWNLG-UHFFFAOYSA-N 0.000 claims 1
- IGMPWTRPXGOCHS-UHFFFAOYSA-N 1-(cyclopropylmethyl)-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N1=CC2=C(NC3CCOCC3)C(C=3CC4(CCC4)ON=3)=CN=C2N1CC1CC1 IGMPWTRPXGOCHS-UHFFFAOYSA-N 0.000 claims 1
- GYFPTAYEBLSOGG-UHFFFAOYSA-N 1-[(4-methoxyphenyl)methyl]-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound C1=CC(OC)=CC=C1CN1C2=NC=C(C=3CC4(CCCC4)ON=3)C(NC3CCOCC3)=C2C=N1 GYFPTAYEBLSOGG-UHFFFAOYSA-N 0.000 claims 1
- LXCJOEZUGGCDIV-UHFFFAOYSA-N 1-[(4-methoxyphenyl)methyl]-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound C1=CC(OC)=CC=C1CN1C2=NC=C(C=3CC4(ON=3)CCCCC4)C(NC3CCOCC3)=C2C=N1 LXCJOEZUGGCDIV-UHFFFAOYSA-N 0.000 claims 1
- PVJUEQVHBIFETG-UHFFFAOYSA-N 1-[(4-methoxyphenyl)methyl]-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound C1=CC(OC)=CC=C1CN1C2=NC=C(C=3CC4(CCC4)ON=3)C(NC3CCOCC3)=C2C=N1 PVJUEQVHBIFETG-UHFFFAOYSA-N 0.000 claims 1
- HAVHTLDFDUYFRU-UHFFFAOYSA-N 1-[(4-methoxyphenyl)methyl]-n-(oxan-4-yl)-5-(2-phenylmethoxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound C1=CC(OC)=CC=C1CN1C2=NC=C(C=3CC4(CC(C4)OCC=4C=CC=CC=4)ON=3)C(NC3CCOCC3)=C2C=N1 HAVHTLDFDUYFRU-UHFFFAOYSA-N 0.000 claims 1
- WREXZTSEBLTXAX-UHFFFAOYSA-N 1-[(4-methoxyphenyl)methyl]-n-(oxan-4-yl)-5-(4,9,12-trioxa-3-azadispiro[4.2.4^{8}.2^{5}]tetradec-2-en-2-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound C1=CC(OC)=CC=C1CN1C2=NC=C(C=3CC4(ON=3)CCC3(CC4)OCCO3)C(NC3CCOCC3)=C2C=N1 WREXZTSEBLTXAX-UHFFFAOYSA-N 0.000 claims 1
- FXWCIVCUNGBMOK-UHFFFAOYSA-N 1-[(4-methoxyphenyl)methyl]-n-(oxan-4-yl)-5-[2-(phenylmethoxymethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]pyrazolo[3,4-b]pyridin-4-amine Chemical compound C1=CC(OC)=CC=C1CN1C2=NC=C(C=3CC4(CC(COCC=5C=CC=CC=5)C4)ON=3)C(NC3CCOCC3)=C2C=N1 FXWCIVCUNGBMOK-UHFFFAOYSA-N 0.000 claims 1
- AXZYIQDVDKWBGB-UHFFFAOYSA-N 1-[3-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]ethanone Chemical compound N=1OC2(CCN(CC2)C(C)=O)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 AXZYIQDVDKWBGB-UHFFFAOYSA-N 0.000 claims 1
- XQRAHBXMZNTQMW-UHFFFAOYSA-N 1-butyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CCCC)N=CC2=C1NC1CCOCC1 XQRAHBXMZNTQMW-UHFFFAOYSA-N 0.000 claims 1
- MENNUEDHXUHZOW-UHFFFAOYSA-N 1-cyclopentyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound C1CCCC1N1C2=NC=C(C=3CC4(CCCC4)ON=3)C(NC3CCOCC3)=C2C=N1 MENNUEDHXUHZOW-UHFFFAOYSA-N 0.000 claims 1
- YMIYGXSCWRBZGA-UHFFFAOYSA-N 1-cyclopentyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound C1CCCC1N1C2=NC=C(C=3CC4(ON=3)CCCCC4)C(NC3CCOCC3)=C2C=N1 YMIYGXSCWRBZGA-UHFFFAOYSA-N 0.000 claims 1
- CBJXSYDXPOWJOP-UHFFFAOYSA-N 1-ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCOCC1 CBJXSYDXPOWJOP-UHFFFAOYSA-N 0.000 claims 1
- JUYLBPKKTFJJIS-UHFFFAOYSA-N 1-ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCOCC1 JUYLBPKKTFJJIS-UHFFFAOYSA-N 0.000 claims 1
- ZGDOJPHJVMSVIC-UHFFFAOYSA-N 1-ethyl-3-methyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCOCC1 ZGDOJPHJVMSVIC-UHFFFAOYSA-N 0.000 claims 1
- PHVPHRJULHFNEF-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(1,2,4-triazin-3-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=NC=CN=N1 PHVPHRJULHFNEF-UHFFFAOYSA-N 0.000 claims 1
- ASMWLGBIOREDJQ-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(1,2,4-triazin-5-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CN=NC=N1 ASMWLGBIOREDJQ-UHFFFAOYSA-N 0.000 claims 1
- UURAWHVLDGPHEK-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(1,2,4-triazol-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NN1C=NN=C1 UURAWHVLDGPHEK-UHFFFAOYSA-N 0.000 claims 1
- UFKSYNRZBZDMGM-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(1-propan-2-ylpiperidin-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(C)C)CC1 UFKSYNRZBZDMGM-UHFFFAOYSA-N 0.000 claims 1
- HKDBWBKWDRPSPJ-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 HKDBWBKWDRPSPJ-UHFFFAOYSA-N 0.000 claims 1
- ZZLNQJZHTPLNJU-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-piperidin-4-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCNCC1 ZZLNQJZHTPLNJU-UHFFFAOYSA-N 0.000 claims 1
- CKTXTEHCGBRNPG-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-pyrazin-2-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CN=CC=N1 CKTXTEHCGBRNPG-UHFFFAOYSA-N 0.000 claims 1
- WEBBKLMVBKDTMU-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-pyridin-2-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CC=CC=N1 WEBBKLMVBKDTMU-UHFFFAOYSA-N 0.000 claims 1
- LFUHYQRYXVUOLV-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-pyridin-3-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CC=CN=C1 LFUHYQRYXVUOLV-UHFFFAOYSA-N 0.000 claims 1
- NNJDRYKVEUFUHG-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-pyridin-4-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CC=NC=C1 NNJDRYKVEUFUHG-UHFFFAOYSA-N 0.000 claims 1
- IZTRKCIWIGVZKE-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-pyrimidin-2-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=NC=CC=N1 IZTRKCIWIGVZKE-UHFFFAOYSA-N 0.000 claims 1
- CWTRIHWOUYCONO-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-pyrimidin-5-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CN=CN=C1 CWTRIHWOUYCONO-UHFFFAOYSA-N 0.000 claims 1
- OKOGEYGAUZXTFL-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(1,2,4-triazin-3-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=NC=CN=N1 OKOGEYGAUZXTFL-UHFFFAOYSA-N 0.000 claims 1
- KKSJLCWBELXIPP-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(1,2,4-triazin-5-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CN=NC=N1 KKSJLCWBELXIPP-UHFFFAOYSA-N 0.000 claims 1
- PGJALNZVFZCADV-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(1,2,4-triazol-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NN1C=NN=C1 PGJALNZVFZCADV-UHFFFAOYSA-N 0.000 claims 1
- DETSAEAHDBMFRP-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(1-propan-2-ylpiperidin-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(C)C)CC1 DETSAEAHDBMFRP-UHFFFAOYSA-N 0.000 claims 1
- XXOZRCGDOABQAK-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 XXOZRCGDOABQAK-UHFFFAOYSA-N 0.000 claims 1
- KBKPLHRTOJGKEY-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-pyrazin-2-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CN=CC=N1 KBKPLHRTOJGKEY-UHFFFAOYSA-N 0.000 claims 1
- PCHNFUGHAUXDKD-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-pyridin-3-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CC=CN=C1 PCHNFUGHAUXDKD-UHFFFAOYSA-N 0.000 claims 1
- XDRNKQGDPXPDHO-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-pyridin-4-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CC=NC=C1 XDRNKQGDPXPDHO-UHFFFAOYSA-N 0.000 claims 1
- GSLICEYSWWLEJE-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-pyrimidin-2-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=NC=CC=N1 GSLICEYSWWLEJE-UHFFFAOYSA-N 0.000 claims 1
- RBWTVNGDXHCYEZ-UHFFFAOYSA-N 1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-pyrimidin-5-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CN=CN=C1 RBWTVNGDXHCYEZ-UHFFFAOYSA-N 0.000 claims 1
- QRLWMYJHORRBOM-UHFFFAOYSA-N 1-ethyl-5-(2-methoxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CC(C2)OC)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 QRLWMYJHORRBOM-UHFFFAOYSA-N 0.000 claims 1
- TXNPWKGTGZHWND-UHFFFAOYSA-N 1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(1,2,4-triazin-3-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=NC=CN=N1 TXNPWKGTGZHWND-UHFFFAOYSA-N 0.000 claims 1
- MBQDYHCYKKLXNX-UHFFFAOYSA-N 1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(1,2,4-triazin-5-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CN=NC=N1 MBQDYHCYKKLXNX-UHFFFAOYSA-N 0.000 claims 1
- VLYZBRLAOQQVHZ-UHFFFAOYSA-N 1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(1,2,4-triazol-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NN1C=NN=C1 VLYZBRLAOQQVHZ-UHFFFAOYSA-N 0.000 claims 1
- RAROPZJHRXYLQU-UHFFFAOYSA-N 1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 RAROPZJHRXYLQU-UHFFFAOYSA-N 0.000 claims 1
- RHDJWGBAXJNGOX-UHFFFAOYSA-N 1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-pyrazin-2-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CN=CC=N1 RHDJWGBAXJNGOX-UHFFFAOYSA-N 0.000 claims 1
- FJMZHCMNMMDUTA-UHFFFAOYSA-N 1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-pyridin-2-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CC=CC=N1 FJMZHCMNMMDUTA-UHFFFAOYSA-N 0.000 claims 1
- RZVAPQLJHARZBN-UHFFFAOYSA-N 1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-pyridin-3-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CC=CN=C1 RZVAPQLJHARZBN-UHFFFAOYSA-N 0.000 claims 1
- BOZIXLUETVRRFG-UHFFFAOYSA-N 1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-pyridin-4-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CC=NC=C1 BOZIXLUETVRRFG-UHFFFAOYSA-N 0.000 claims 1
- PTKHCWLEXIJUAC-UHFFFAOYSA-N 1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-pyrimidin-2-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=NC=CC=N1 PTKHCWLEXIJUAC-UHFFFAOYSA-N 0.000 claims 1
- VIJUSZFKDFGSTF-UHFFFAOYSA-N 1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-pyrimidin-5-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CN=CN=C1 VIJUSZFKDFGSTF-UHFFFAOYSA-N 0.000 claims 1
- YOMHHVXQMHKKHM-UHFFFAOYSA-N 1-ethyl-5-(8-methoxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC(CC2)OC)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 YOMHHVXQMHKKHM-UHFFFAOYSA-N 0.000 claims 1
- AWSHZKQFDBXYBW-UHFFFAOYSA-N 1-ethyl-5-[2-(methoxymethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CC(COC)C2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 AWSHZKQFDBXYBW-UHFFFAOYSA-N 0.000 claims 1
- ISTFZZQUYLJHML-UHFFFAOYSA-N 1-ethyl-n-(1-methylsulfonylpiperidin-4-yl)-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCN(S(C)(=O)=O)CC1 ISTFZZQUYLJHML-UHFFFAOYSA-N 0.000 claims 1
- JUHSOGMNSCYMBG-UHFFFAOYSA-N 1-ethyl-n-(3-methoxyphenyl)-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=CC=CC(OC)=C1 JUHSOGMNSCYMBG-UHFFFAOYSA-N 0.000 claims 1
- WHIPSDUFQLYLLF-UHFFFAOYSA-N 1-ethyl-n-(furan-3-yl)-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC=1C=COC=1 WHIPSDUFQLYLLF-UHFFFAOYSA-N 0.000 claims 1
- FJBHBJZJJOAYRM-UHFFFAOYSA-N 1-ethyl-n-(furan-3-yl)-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC=1C=COC=1 FJBHBJZJJOAYRM-UHFFFAOYSA-N 0.000 claims 1
- ODYKBGIIXCDDRC-UHFFFAOYSA-N 1-ethyl-n-(furan-3-yl)-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC=1C=COC=1 ODYKBGIIXCDDRC-UHFFFAOYSA-N 0.000 claims 1
- YMDNHDMAGHASRM-UHFFFAOYSA-N 1-ethyl-n-(oxan-4-yl)-5-(2-phenylmethoxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CC(C2)OCC=2C=CC=CC=2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 YMDNHDMAGHASRM-UHFFFAOYSA-N 0.000 claims 1
- XFLYAAFENCGPPE-UHFFFAOYSA-N 1-ethyl-n-(oxan-4-yl)-5-[2-(phenylmethoxymethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CC(COCC=3C=CC=CC=3)C2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 XFLYAAFENCGPPE-UHFFFAOYSA-N 0.000 claims 1
- XAPOPSQIGWKVSQ-UHFFFAOYSA-N 1-methyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(C)N=CC2=C1NC1CCOCC1 XAPOPSQIGWKVSQ-UHFFFAOYSA-N 0.000 claims 1
- LMAHAECOIZLKRE-UHFFFAOYSA-N 1-methyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(C)N=CC2=C1NC1CCOCC1 LMAHAECOIZLKRE-UHFFFAOYSA-N 0.000 claims 1
- 125000004484 1-methylpiperidin-4-yl group Chemical group CN1CCC(CC1)* 0.000 claims 1
- JJISQWLMMLKYIE-UHFFFAOYSA-N 1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid Chemical compound C1CC(C(=O)O)CCC11ON=CC1 JJISQWLMMLKYIE-UHFFFAOYSA-N 0.000 claims 1
- JKMBIVBDPRKZLZ-UHFFFAOYSA-N 2-[4-[[1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-yl]amino]piperidin-1-yl]ethanol Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCN(CCO)CC1 JKMBIVBDPRKZLZ-UHFFFAOYSA-N 0.000 claims 1
- NWYADLATGGTWPM-UHFFFAOYSA-N 2-[4-[[1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-yl]amino]piperidin-1-yl]ethanol Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCN(CCO)CC1 NWYADLATGGTWPM-UHFFFAOYSA-N 0.000 claims 1
- CJRPBHHLYSKXHV-UHFFFAOYSA-N 2-ethylnon-7-enamide Chemical compound CCC(C(N)=O)CCCCC=CC CJRPBHHLYSKXHV-UHFFFAOYSA-N 0.000 claims 1
- IEZHYBMZLUJJRU-UHFFFAOYSA-N 2-ethylnon-7-enenitrile Chemical compound CC=CCCCCC(CC)C#N IEZHYBMZLUJJRU-UHFFFAOYSA-N 0.000 claims 1
- FMIWWCKEUYCQGE-UHFFFAOYSA-N 2-ethylnon-7-enoic acid Chemical compound CCC(CCCCC=CC)C(=O)O FMIWWCKEUYCQGE-UHFFFAOYSA-N 0.000 claims 1
- PIGIMRROAYXZDP-UHFFFAOYSA-N 3-[1-[(4-methoxyphenyl)methyl]-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-one Chemical compound C1=CC(OC)=CC=C1CN1C2=NC=C(C=3CC4(ON=3)CCC(=O)CC4)C(NC3CCOCC3)=C2C=N1 PIGIMRROAYXZDP-UHFFFAOYSA-N 0.000 claims 1
- AJXWPAWGCMTYMK-UHFFFAOYSA-N 3-[1-ethyl-3-methyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-ol Chemical compound N=1OC2(CCC(O)CC2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCOCC1 AJXWPAWGCMTYMK-UHFFFAOYSA-N 0.000 claims 1
- IWHACMKLOIVQNT-UHFFFAOYSA-N 3-[1-ethyl-3-methyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carbonitrile Chemical compound N=1OC2(CCC(CC2)C#N)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCOCC1 IWHACMKLOIVQNT-UHFFFAOYSA-N 0.000 claims 1
- VIVXIIYQDGLHSE-UHFFFAOYSA-N 3-[1-ethyl-3-methyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid Chemical compound N=1OC2(CCC(CC2)C(O)=O)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCOCC1 VIVXIIYQDGLHSE-UHFFFAOYSA-N 0.000 claims 1
- PPBJAUYNTYFPHR-UHFFFAOYSA-N 3-[1-ethyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-one Chemical compound N=1OC2(CCC(=O)CC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 PPBJAUYNTYFPHR-UHFFFAOYSA-N 0.000 claims 1
- POKNTTBBOMSBHT-UHFFFAOYSA-N 3-[1-ethyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid Chemical compound N=1OC2(CCC(CC2)C(O)=O)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 POKNTTBBOMSBHT-UHFFFAOYSA-N 0.000 claims 1
- BLCLOLSXRUPDRG-UHFFFAOYSA-N 3-[1-ethyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-n-methyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide Chemical compound N=1OC2(CCC(CC2)C(=O)NC)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 BLCLOLSXRUPDRG-UHFFFAOYSA-N 0.000 claims 1
- GAIQGGCHLRSVSR-UHFFFAOYSA-N 3-[1-ethyl-4-[(3-hydroxycyclobutyl)amino]pyrazolo[3,4-b]pyridin-5-yl]-n-methyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide Chemical compound N=1OC2(CCC(CC2)C(=O)NC)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CC(O)C1 GAIQGGCHLRSVSR-UHFFFAOYSA-N 0.000 claims 1
- OBPQUIBZXOXZFU-UHFFFAOYSA-N 3-[1-ethyl-4-[(4-hydroxycyclohexyl)amino]pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-one Chemical compound N=1OC2(CCC(=O)CC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCC(O)CC1 OBPQUIBZXOXZFU-UHFFFAOYSA-N 0.000 claims 1
- WWIIZLITSLSOHQ-UHFFFAOYSA-N 3-[4-(cyclohexylamino)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-ol Chemical compound N=1OC2(CCC(O)CC2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCCCC1 WWIIZLITSLSOHQ-UHFFFAOYSA-N 0.000 claims 1
- WMWMHHZBYGIHAE-UHFFFAOYSA-N 3-[4-(cyclohexylamino)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carbonitrile Chemical compound N=1OC2(CCC(CC2)C#N)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCCCC1 WMWMHHZBYGIHAE-UHFFFAOYSA-N 0.000 claims 1
- QKFBAAYGFXITMF-UHFFFAOYSA-N 3-[4-(cyclohexylamino)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid Chemical compound N=1OC2(CCC(CC2)C(O)=O)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCCCC1 QKFBAAYGFXITMF-UHFFFAOYSA-N 0.000 claims 1
- WSFZLRKSXGERLZ-UHFFFAOYSA-N 3-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-amine Chemical compound N=1OC2(CCC(N)CC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 WSFZLRKSXGERLZ-UHFFFAOYSA-N 0.000 claims 1
- QINWEWNNDPXFOJ-UHFFFAOYSA-N 3-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-one Chemical compound N=1OC2(CCC(=O)CC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 QINWEWNNDPXFOJ-UHFFFAOYSA-N 0.000 claims 1
- HZJBYJQUGDNCQI-UHFFFAOYSA-N 3-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carbonitrile Chemical compound N=1OC2(CCC(CC2)C#N)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 HZJBYJQUGDNCQI-UHFFFAOYSA-N 0.000 claims 1
- QULVHEMBUNFXOC-UHFFFAOYSA-N 3-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-n-cyclopropyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide Chemical compound N=1OC2(CCC(CC2)C(=O)NC2CC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 QULVHEMBUNFXOC-UHFFFAOYSA-N 0.000 claims 1
- GTJZTEVBXMUONA-UHFFFAOYSA-N 3-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-n-ethyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide Chemical compound C1CC(C(=O)NCC)CCC11ON=C(C=2C(=C3C=NN(CC)C3=NC=2)NC2CCCCC2)C1 GTJZTEVBXMUONA-UHFFFAOYSA-N 0.000 claims 1
- DAFXMEQOABZZNT-UHFFFAOYSA-N 3-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-n-methyl-1-oxa-2-azaspiro[4.5]dec-2-en-8-amine Chemical compound N=1OC2(CCC(CC2)NC)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 DAFXMEQOABZZNT-UHFFFAOYSA-N 0.000 claims 1
- HLDGIASLLBAGBM-UHFFFAOYSA-N 3-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-n-methyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide Chemical compound N=1OC2(CCC(CC2)C(=O)NC)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 HLDGIASLLBAGBM-UHFFFAOYSA-N 0.000 claims 1
- NTIZHSUHOCODBE-UHFFFAOYSA-N 3-[4-[(4-carboxycyclohexyl)amino]-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid Chemical compound N=1OC2(CCC(CC2)C(O)=O)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCC(C(O)=O)CC1 NTIZHSUHOCODBE-UHFFFAOYSA-N 0.000 claims 1
- UCSDKOFCALOSHG-UHFFFAOYSA-N 3-[4-[(4-carboxycyclohexyl)amino]-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid Chemical compound N=1OC2(CCC(CC2)C(O)=O)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(O)=O)CC1 UCSDKOFCALOSHG-UHFFFAOYSA-N 0.000 claims 1
- ZYUFYQLRIBZSOR-UHFFFAOYSA-N 3-[[1-ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-yl]amino]cyclobutane-1-carboxylic acid Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CC(C(O)=O)C1 ZYUFYQLRIBZSOR-UHFFFAOYSA-N 0.000 claims 1
- OFHRSRDKFXNNPG-UHFFFAOYSA-N 3-[[1-ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-yl]amino]cyclobutane-1-carboxylic acid Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CC(C(O)=O)C1 OFHRSRDKFXNNPG-UHFFFAOYSA-N 0.000 claims 1
- ZCYPGFUSSSQITG-UHFFFAOYSA-N 3-[[1-ethyl-3-methyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)pyrazolo[3,4-b]pyridin-4-yl]amino]cyclobutane-1-carboxylic acid Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CC(C(O)=O)C1 ZCYPGFUSSSQITG-UHFFFAOYSA-N 0.000 claims 1
- KWSLKXOMBGDOGL-UHFFFAOYSA-N 3-[[1-ethyl-3-methyl-5-[2-(propanoylamino)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]pyrazolo[3,4-b]pyridin-4-yl]amino]cyclobutane-1-carboxylic acid Chemical compound C1C(NC(=O)CC)CC21ON=C(C=1C(=C3C(C)=NN(CC)C3=NC=1)NC1CC(C1)C(O)=O)C2 KWSLKXOMBGDOGL-UHFFFAOYSA-N 0.000 claims 1
- LVIKXZDERZQDIU-UHFFFAOYSA-N 3-[[1-ethyl-5-(2-hydroxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-3-methylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclobutane-1-carboxylic acid Chemical compound N=1OC2(CC(O)C2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CC(C(O)=O)C1 LVIKXZDERZQDIU-UHFFFAOYSA-N 0.000 claims 1
- KNJXXFJHUBTDOO-UHFFFAOYSA-N 3-[[1-ethyl-5-(2-hydroxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)pyrazolo[3,4-b]pyridin-4-yl]amino]cyclobutane-1-carboxylic acid Chemical compound N=1OC2(CC(O)C2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CC(C(O)=O)C1 KNJXXFJHUBTDOO-UHFFFAOYSA-N 0.000 claims 1
- IGHORDRHHKKZJZ-UHFFFAOYSA-N 3-[[1-ethyl-5-(8-hydroxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-yl]amino]cyclobutane-1-carboxylic acid Chemical compound N=1OC2(CCC(O)CC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CC(C(O)=O)C1 IGHORDRHHKKZJZ-UHFFFAOYSA-N 0.000 claims 1
- KPDHDBQWOXOGPG-UHFFFAOYSA-N 3-[[5-(2-acetamido-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclobutane-1-carboxylic acid Chemical compound N=1OC2(CC(C2)NC(C)=O)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CC(C(O)=O)C1 KPDHDBQWOXOGPG-UHFFFAOYSA-N 0.000 claims 1
- PGZJBOKWFLDJTE-UHFFFAOYSA-N 3-[[5-(2-amino-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclobutane-1-carboxylic acid Chemical compound N=1OC2(CC(N)C2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CC(C(O)=O)C1 PGZJBOKWFLDJTE-UHFFFAOYSA-N 0.000 claims 1
- KIXZJKIEIOOZQP-UHFFFAOYSA-N 3-[[5-(2-cyano-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclobutane-1-carboxylic acid Chemical compound N=1OC2(CC(C2)C#N)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CC(C(O)=O)C1 KIXZJKIEIOOZQP-UHFFFAOYSA-N 0.000 claims 1
- SQVOMTDANVBANE-UHFFFAOYSA-N 3-[[5-(2-cyano-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclobutane-1-carboxylic acid Chemical compound N=1OC2(CC(C2)C#N)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CC(C(O)=O)C1 SQVOMTDANVBANE-UHFFFAOYSA-N 0.000 claims 1
- ZBZDITMBKILWII-UHFFFAOYSA-N 3-[[5-(8-carbamoyl-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclobutane-1-carboxylic acid Chemical compound N=1OC2(CCC(CC2)C(N)=O)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CC(C(O)=O)C1 ZBZDITMBKILWII-UHFFFAOYSA-N 0.000 claims 1
- XYAVXVGQZABIEL-UHFFFAOYSA-N 4-[[1-ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCC(C(O)=O)CC1 XYAVXVGQZABIEL-UHFFFAOYSA-N 0.000 claims 1
- KQBIZFDBTIEOAK-UHFFFAOYSA-N 4-[[1-ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCC(C(O)=O)CC1 KQBIZFDBTIEOAK-UHFFFAOYSA-N 0.000 claims 1
- AWHQDYOFKUYUNZ-UHFFFAOYSA-N 4-[[1-ethyl-3-methyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)pyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCC(C(O)=O)CC1 AWHQDYOFKUYUNZ-UHFFFAOYSA-N 0.000 claims 1
- CBXUPDVQNWMCFS-UHFFFAOYSA-N 4-[[1-ethyl-3-methyl-5-[2-(methylcarbamoyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]pyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CC(C2)C(=O)NC)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCC(C(O)=O)CC1 CBXUPDVQNWMCFS-UHFFFAOYSA-N 0.000 claims 1
- HTSPFHXLQCIYJT-UHFFFAOYSA-N 4-[[1-ethyl-3-methyl-5-[8-(methylcarbamoyl)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]pyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CCC(CC2)C(=O)NC)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCC(C(O)=O)CC1 HTSPFHXLQCIYJT-UHFFFAOYSA-N 0.000 claims 1
- YSHJSIVBZYQTQO-UHFFFAOYSA-N 4-[[1-ethyl-3-methyl-5-[8-(propanoylamino)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]pyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound C1CC(NC(=O)CC)CCC11ON=C(C=2C(=C3C(C)=NN(CC)C3=NC=2)NC2CCC(CC2)C(O)=O)C1 YSHJSIVBZYQTQO-UHFFFAOYSA-N 0.000 claims 1
- UFHRLQXLDNCYQN-UHFFFAOYSA-N 4-[[1-ethyl-5-(2-hydroxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-3-methylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CC(O)C2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCC(C(O)=O)CC1 UFHRLQXLDNCYQN-UHFFFAOYSA-N 0.000 claims 1
- UIBYFWAHRIBZPE-UHFFFAOYSA-N 4-[[1-ethyl-5-(8-hydroxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CCC(O)CC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(O)=O)CC1 UIBYFWAHRIBZPE-UHFFFAOYSA-N 0.000 claims 1
- CGPLMIXJJVJOSU-UHFFFAOYSA-N 4-[[1-ethyl-5-(8-methoxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CCC(CC2)OC)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(O)=O)CC1 CGPLMIXJJVJOSU-UHFFFAOYSA-N 0.000 claims 1
- CBYBBQGERQVJQH-UHFFFAOYSA-N 4-[[1-ethyl-5-[2-(ethylcarbamoyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-3-methylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound C1C(C(=O)NCC)CC21ON=C(C=1C(=C3C(C)=NN(CC)C3=NC=1)NC1CCC(CC1)C(O)=O)C2 CBYBBQGERQVJQH-UHFFFAOYSA-N 0.000 claims 1
- QDBNXZVVAGHTRE-UHFFFAOYSA-N 4-[[1-ethyl-5-[8-(ethylcarbamoyl)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-3-methylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound C1CC(C(=O)NCC)CCC11ON=C(C=2C(=C3C(C)=NN(CC)C3=NC=2)NC2CCC(CC2)C(O)=O)C1 QDBNXZVVAGHTRE-UHFFFAOYSA-N 0.000 claims 1
- VQNGQFCOGVEGHI-UHFFFAOYSA-N 4-[[5-(2-carbamoyl-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CC(C2)C(N)=O)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCC(C(O)=O)CC1 VQNGQFCOGVEGHI-UHFFFAOYSA-N 0.000 claims 1
- YTCHCTWWODHXOJ-UHFFFAOYSA-N 4-[[5-(2-carbamoyl-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CC(C2)C(N)=O)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(O)=O)CC1 YTCHCTWWODHXOJ-UHFFFAOYSA-N 0.000 claims 1
- OJRQLMUUVTVELN-UHFFFAOYSA-N 4-[[5-(2-cyano-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CC(C2)C#N)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCC(C(O)=O)CC1 OJRQLMUUVTVELN-UHFFFAOYSA-N 0.000 claims 1
- XVYRGABPKZHYST-UHFFFAOYSA-N 4-[[5-(2-cyano-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CC(C2)C#N)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(O)=O)CC1 XVYRGABPKZHYST-UHFFFAOYSA-N 0.000 claims 1
- GTHSHAZXVCHSHJ-UHFFFAOYSA-N 4-[[5-(8-acetamido-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CCC(CC2)NC(C)=O)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCC(C(O)=O)CC1 GTHSHAZXVCHSHJ-UHFFFAOYSA-N 0.000 claims 1
- BBCQRUAZUVLJMR-UHFFFAOYSA-N 4-[[5-(8-amino-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CCC(N)CC2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCC(C(O)=O)CC1 BBCQRUAZUVLJMR-UHFFFAOYSA-N 0.000 claims 1
- WFASOWPGQHGRDY-UHFFFAOYSA-N 4-[[5-(8-amino-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CCC(N)CC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(O)=O)CC1 WFASOWPGQHGRDY-UHFFFAOYSA-N 0.000 claims 1
- CIILTBAAFOELMI-UHFFFAOYSA-N 4-[[5-(8-carbamoyl-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound N=1OC2(CCC(CC2)C(N)=O)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCC(C(O)=O)CC1 CIILTBAAFOELMI-UHFFFAOYSA-N 0.000 claims 1
- SMOSWOHLBJVHHB-UHFFFAOYSA-N 4-[[5-(8-ethoxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethylpyrazolo[3,4-b]pyridin-4-yl]amino]cyclohexane-1-carboxylic acid Chemical compound C1CC(OCC)CCC11ON=C(C=2C(=C3C=NN(CC)C3=NC=2)NC2CCC(CC2)C(O)=O)C1 SMOSWOHLBJVHHB-UHFFFAOYSA-N 0.000 claims 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 claims 1
- WSZRIVZUGHLISE-UHFFFAOYSA-N 5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(oxan-4-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC(F)(F)F)N=CC2=C1NC1CCOCC1 WSZRIVZUGHLISE-UHFFFAOYSA-N 0.000 claims 1
- RIUHDDWKKIFDDQ-UHFFFAOYSA-N 5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(oxan-4-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(C(C)C)N=CC2=C1NC1CCOCC1 RIUHDDWKKIFDDQ-UHFFFAOYSA-N 0.000 claims 1
- BZJXFAPKHFPWOL-UHFFFAOYSA-N 5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-n-(oxan-4-yl)-1-propylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CCC)N=CC2=C1NC1CCOCC1 BZJXFAPKHFPWOL-UHFFFAOYSA-N 0.000 claims 1
- YXXGQMRJSOKODH-UHFFFAOYSA-N 5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(oxan-4-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(C(C)C)N=CC2=C1NC1CCOCC1 YXXGQMRJSOKODH-UHFFFAOYSA-N 0.000 claims 1
- QVKJYDMZHARKTR-UHFFFAOYSA-N 5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(oxan-4-yl)-1-propylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CCC)N=CC2=C1NC1CCOCC1 QVKJYDMZHARKTR-UHFFFAOYSA-N 0.000 claims 1
- OACURABESMMQKA-UHFFFAOYSA-N 5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-n-(oxan-4-yl)-1h-pyrazolo[3,4-b]pyridin-4-amine Chemical compound C1C(C=2C(=C3C=NNC3=NC=2)NC2CCOCC2)=NOC11CCCCC1 OACURABESMMQKA-UHFFFAOYSA-N 0.000 claims 1
- QLVSSTBIEQAWED-UHFFFAOYSA-N 5-(2-ethoxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound C1C(OCC)CC21ON=C(C=1C(=C3C=NN(CC)C3=NC=1)NC1CCOCC1)C2 QLVSSTBIEQAWED-UHFFFAOYSA-N 0.000 claims 1
- NTDSLUBWNSYACN-UHFFFAOYSA-N 5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(oxan-4-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC(F)(F)F)N=CC2=C1NC1CCOCC1 NTDSLUBWNSYACN-UHFFFAOYSA-N 0.000 claims 1
- IQXZEVXJPIPQBA-UHFFFAOYSA-N 5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(oxan-4-yl)-1-propan-2-ylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(C(C)C)N=CC2=C1NC1CCOCC1 IQXZEVXJPIPQBA-UHFFFAOYSA-N 0.000 claims 1
- IFDXQBMAEOUVHI-UHFFFAOYSA-N 5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(oxan-4-yl)-1-propylpyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CCC)N=CC2=C1NC1CCOCC1 IFDXQBMAEOUVHI-UHFFFAOYSA-N 0.000 claims 1
- GHOBQQMKHXQKJL-UHFFFAOYSA-N 5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-n-(oxan-4-yl)-1h-pyrazolo[3,4-b]pyridin-4-amine Chemical compound C1CCC21ON=C(C=1C(=C3C=NNC3=NC=1)NC1CCOCC1)C2 GHOBQQMKHXQKJL-UHFFFAOYSA-N 0.000 claims 1
- CUOABBOYZKRIDB-UHFFFAOYSA-N 5-[2-(aminomethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1-ethyl-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CC(CN)C2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 CUOABBOYZKRIDB-UHFFFAOYSA-N 0.000 claims 1
- QBLFCFZYHKWAEJ-UHFFFAOYSA-N 5-[2-(ethoxymethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1-ethyl-n-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound C1C(COCC)CC21ON=C(C=1C(=C3C=NN(CC)C3=NC=1)NC1CCOCC1)C2 QBLFCFZYHKWAEJ-UHFFFAOYSA-N 0.000 claims 1
- ZUOUNEZWPTYOQF-UHFFFAOYSA-N 7-[1-ethyl-3-methyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-ol Chemical compound N=1OC2(CC(O)C2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCOCC1 ZUOUNEZWPTYOQF-UHFFFAOYSA-N 0.000 claims 1
- RTBBPFYYKHXNEY-UHFFFAOYSA-N 7-[1-ethyl-3-methyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carbonitrile Chemical compound N=1OC2(CC(C2)C#N)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCOCC1 RTBBPFYYKHXNEY-UHFFFAOYSA-N 0.000 claims 1
- SAUOHRROLLLSHW-UHFFFAOYSA-N 7-[1-ethyl-3-methyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide Chemical compound N=1OC2(CC(C2)C(N)=O)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCOCC1 SAUOHRROLLLSHW-UHFFFAOYSA-N 0.000 claims 1
- OZUJBUPJMYOSMD-UHFFFAOYSA-N 7-[1-ethyl-3-methyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylic acid Chemical compound N=1OC2(CC(C2)C(O)=O)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCOCC1 OZUJBUPJMYOSMD-UHFFFAOYSA-N 0.000 claims 1
- HPMRQIJYOPRJQX-UHFFFAOYSA-N 7-[1-ethyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-amine Chemical compound N=1OC2(CC(N)C2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 HPMRQIJYOPRJQX-UHFFFAOYSA-N 0.000 claims 1
- DYTFKEFWANZBQA-UHFFFAOYSA-N 7-[1-ethyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carbonitrile Chemical compound N=1OC2(CC(C2)C#N)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 DYTFKEFWANZBQA-UHFFFAOYSA-N 0.000 claims 1
- AATZSBIXYVDCLC-UHFFFAOYSA-N 7-[1-ethyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide Chemical compound N=1OC2(CC(C2)C(N)=O)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 AATZSBIXYVDCLC-UHFFFAOYSA-N 0.000 claims 1
- CTXWWGPRLOJOFH-UHFFFAOYSA-N 7-[1-ethyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylic acid Chemical compound N=1OC2(CC(C2)C(O)=O)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 CTXWWGPRLOJOFH-UHFFFAOYSA-N 0.000 claims 1
- MNUUVAWXJHHYGB-UHFFFAOYSA-N 7-[1-ethyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-n-methyl-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide Chemical compound N=1OC2(CC(C2)C(=O)NC)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 MNUUVAWXJHHYGB-UHFFFAOYSA-N 0.000 claims 1
- FIHLXRINWKYMSG-UHFFFAOYSA-N 7-[4-(cyclohexylamino)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-amine Chemical compound N=1OC2(CC(N)C2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCCCC1 FIHLXRINWKYMSG-UHFFFAOYSA-N 0.000 claims 1
- QNBTUUPGBLZYAM-UHFFFAOYSA-N 7-[4-(cyclohexylamino)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-ol Chemical compound N=1OC2(CC(O)C2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCCCC1 QNBTUUPGBLZYAM-UHFFFAOYSA-N 0.000 claims 1
- FYGMVYOTBQGOIZ-UHFFFAOYSA-N 7-[4-(cyclohexylamino)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carbonitrile Chemical compound N=1OC2(CC(C2)C#N)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCCCC1 FYGMVYOTBQGOIZ-UHFFFAOYSA-N 0.000 claims 1
- UVQCVCVGIHDDKD-UHFFFAOYSA-N 7-[4-(cyclohexylamino)-1-ethyl-3-methylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylic acid Chemical compound N=1OC2(CC(C2)C(O)=O)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCCCC1 UVQCVCVGIHDDKD-UHFFFAOYSA-N 0.000 claims 1
- ZKXZADHDNONZPO-UHFFFAOYSA-N 7-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-amine Chemical compound N=1OC2(CC(N)C2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 ZKXZADHDNONZPO-UHFFFAOYSA-N 0.000 claims 1
- RPTZWBXGFLUJJM-UHFFFAOYSA-N 7-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-ol Chemical compound N=1OC2(CC(O)C2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 RPTZWBXGFLUJJM-UHFFFAOYSA-N 0.000 claims 1
- LBQUIYPYQXKGEC-UHFFFAOYSA-N 7-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carbonitrile Chemical compound N=1OC2(CC(C2)C#N)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 LBQUIYPYQXKGEC-UHFFFAOYSA-N 0.000 claims 1
- DWJSIPQUGOEIKH-UHFFFAOYSA-N 7-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylic acid Chemical compound N=1OC2(CC(C2)C(O)=O)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 DWJSIPQUGOEIKH-UHFFFAOYSA-N 0.000 claims 1
- XWEFKSONKJDUIF-UHFFFAOYSA-N 7-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-n-cyclopropyl-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide Chemical compound N=1OC2(CC(C2)C(=O)NC2CC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 XWEFKSONKJDUIF-UHFFFAOYSA-N 0.000 claims 1
- IGQYJXHILDATGL-UHFFFAOYSA-N 7-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-n-ethyl-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide Chemical compound C1C(C(=O)NCC)CC21ON=C(C=1C(=C3C=NN(CC)C3=NC=1)NC1CCCCC1)C2 IGQYJXHILDATGL-UHFFFAOYSA-N 0.000 claims 1
- JRSAWJSOTJYQQZ-UHFFFAOYSA-N 7-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-n-methyl-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide Chemical compound N=1OC2(CC(C2)C(=O)NC)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 JRSAWJSOTJYQQZ-UHFFFAOYSA-N 0.000 claims 1
- LJEIIEZWDDCCOF-UHFFFAOYSA-N 7-[4-[(4-carboxycyclohexyl)amino]-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylic acid Chemical compound N=1OC2(CC(C2)C(O)=O)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(O)=O)CC1 LJEIIEZWDDCCOF-UHFFFAOYSA-N 0.000 claims 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims 1
- FPKOSUTWUYBGON-UHFFFAOYSA-N C1C(N2N=CC3=C2N=CC=C3NC2CCNCC2)=NOC11CCCCC1 Chemical compound C1C(N2N=CC3=C2N=CC=C3NC2CCNCC2)=NOC11CCCCC1 FPKOSUTWUYBGON-UHFFFAOYSA-N 0.000 claims 1
- RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 claims 1
- XXROZGKCAVUHQS-UHFFFAOYSA-N FC(CN1N=C(C(C2)=NOC22CCCCC2)C2=C1N=CC=C2NC1CCOCC1)(F)F Chemical compound FC(CN1N=C(C(C2)=NOC22CCCCC2)C2=C1N=CC=C2NC1CCOCC1)(F)F XXROZGKCAVUHQS-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 150000001204 N-oxides Chemical class 0.000 claims 1
- 235000012501 ammonium carbonate Nutrition 0.000 claims 1
- 239000001099 ammonium carbonate Substances 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- VEZUQRBDRNJBJY-UHFFFAOYSA-N cyclohexanone-oximeFRProcd Natural products ON=C1CCCCC1 VEZUQRBDRNJBJY-UHFFFAOYSA-N 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 238000003328 mesylation reaction Methods 0.000 claims 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 1
- RSRBDALFKMRARO-UHFFFAOYSA-N methyl 2-ethylnon-7-enoate Chemical compound CCC(CCCCC=CC)C(=O)OC RSRBDALFKMRARO-UHFFFAOYSA-N 0.000 claims 1
- WPFJONYCJVGAOG-UHFFFAOYSA-N n-(3-methoxyphenyl)-1-[(4-methoxyphenyl)methyl]-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound C1=CC(OC)=CC=C1CN1C2=NC=C(C=3CC4(CCCC4)ON=3)C(NC=3C=C(OC)C=CC=3)=C2C=N1 WPFJONYCJVGAOG-UHFFFAOYSA-N 0.000 claims 1
- PYQBZISJCFZNRD-UHFFFAOYSA-N n-[1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-yl]-1,3-thiazol-2-amine Chemical compound N=1OC2(CCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=NC=CS1 PYQBZISJCFZNRD-UHFFFAOYSA-N 0.000 claims 1
- OGORCVUBONUGDQ-UHFFFAOYSA-N n-[1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-yl]-1,3-thiazol-2-amine Chemical compound N=1OC2(CCCCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=NC=CS1 OGORCVUBONUGDQ-UHFFFAOYSA-N 0.000 claims 1
- DRPVICLHKYYQBQ-UHFFFAOYSA-N n-[1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)pyrazolo[3,4-b]pyridin-4-yl]-1,3-thiazol-2-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1=NC=CS1 DRPVICLHKYYQBQ-UHFFFAOYSA-N 0.000 claims 1
- XUVARQKJQIMAJU-UHFFFAOYSA-N n-[7-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl]acetamide Chemical compound N=1OC2(CC(C2)NC(C)=O)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 XUVARQKJQIMAJU-UHFFFAOYSA-N 0.000 claims 1
- SHUDCRPRBCFQOB-UHFFFAOYSA-N n-[7-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl]propanamide Chemical compound C1C(NC(=O)CC)CC21ON=C(C=1C(=C3C=NN(CC)C3=NC=1)NC1CCCCC1)C2 SHUDCRPRBCFQOB-UHFFFAOYSA-N 0.000 claims 1
- DQTBTQJJSAMYII-UHFFFAOYSA-N n-[[7-[1-ethyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl]methyl]acetamide Chemical compound N=1OC2(CC(CNC(C)=O)C2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 DQTBTQJJSAMYII-UHFFFAOYSA-N 0.000 claims 1
- JGLGPXJGLCCSSW-UHFFFAOYSA-N n-[[7-[1-ethyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl]methyl]propanamide Chemical compound C1C(CNC(=O)CC)CC21ON=C(C=1C(=C3C=NN(CC)C3=NC=1)NC1CCOCC1)C2 JGLGPXJGLCCSSW-UHFFFAOYSA-N 0.000 claims 1
- VTCMZMAQKKKFHY-UHFFFAOYSA-N n-[[7-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl]methyl]acetamide Chemical compound N=1OC2(CC(CNC(C)=O)C2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 VTCMZMAQKKKFHY-UHFFFAOYSA-N 0.000 claims 1
- TWUBYNZAMFNJKI-UHFFFAOYSA-N n-[[7-[4-(cyclohexylamino)-1-ethylpyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl]methyl]propanamide Chemical compound C1C(CNC(=O)CC)CC21ON=C(C=1C(=C3C=NN(CC)C3=NC=1)NC1CCCCC1)C2 TWUBYNZAMFNJKI-UHFFFAOYSA-N 0.000 claims 1
- KPVCMZOIOHMSMW-UHFFFAOYSA-N n-cyclohexyl-1-ethyl-3-methyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=C(C)C2=C1NC1CCCCC1 KPVCMZOIOHMSMW-UHFFFAOYSA-N 0.000 claims 1
- BDHHZQLMLPTXGC-UHFFFAOYSA-N n-cyclohexyl-1-ethyl-5-(1-oxa-2,8-diazaspiro[4.5]dec-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-amine;hydrochloride Chemical compound Cl.N=1OC2(CCNCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 BDHHZQLMLPTXGC-UHFFFAOYSA-N 0.000 claims 1
- WHRWFIMHKJKCTQ-UHFFFAOYSA-N n-cyclohexyl-1-ethyl-5-(1-oxa-7-thia-2-azaspiro[4.4]non-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CSCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 WHRWFIMHKJKCTQ-UHFFFAOYSA-N 0.000 claims 1
- NHIRDVHPYAMNMH-UHFFFAOYSA-N n-cyclohexyl-1-ethyl-5-(2-methoxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CC(C2)OC)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 NHIRDVHPYAMNMH-UHFFFAOYSA-N 0.000 claims 1
- FGFLMSQAOHBQEF-UHFFFAOYSA-N n-cyclohexyl-1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 FGFLMSQAOHBQEF-UHFFFAOYSA-N 0.000 claims 1
- YUPYNUSAKODBBL-UHFFFAOYSA-N n-cyclohexyl-1-ethyl-5-(8-methoxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)pyrazolo[3,4-b]pyridin-4-amine Chemical compound N=1OC2(CCC(CC2)OC)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCCCC1 YUPYNUSAKODBBL-UHFFFAOYSA-N 0.000 claims 1
- PWCTWTKALYLROD-UHFFFAOYSA-N n-cyclohexyl-5-(2-ethoxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethylpyrazolo[3,4-b]pyridin-4-amine Chemical compound C1C(OCC)CC21ON=C(C=1C(=C3C=NN(CC)C3=NC=1)NC1CCCCC1)C2 PWCTWTKALYLROD-UHFFFAOYSA-N 0.000 claims 1
- QDSUIUBBSXQZKO-UHFFFAOYSA-N n-cyclopropyl-3-[1-ethyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide Chemical compound N=1OC2(CCC(CC2)C(=O)NC2CC2)CC=1C1=CN=C2N(CC)N=CC2=C1NC1CCOCC1 QDSUIUBBSXQZKO-UHFFFAOYSA-N 0.000 claims 1
- WXEYRXVDNURQJN-UHFFFAOYSA-N n-ethyl-7-[1-ethyl-3-methyl-4-(oxan-4-ylamino)pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide Chemical compound C1C(C(=O)NCC)CC21ON=C(C=1C(=C3C(C)=NN(CC)C3=NC=1)NC1CCOCC1)C2 WXEYRXVDNURQJN-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 125000003884 phenylalkyl group Chemical group 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 125000006413 ring segment Chemical group 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 125000003003 spiro group Chemical group 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
- 0 *CCc1c(N(*)N=*)ncc(C(C2)=NOC3C2CCCCC3)c1NC(CC1)CCS1(=O)=O Chemical compound *CCc1c(N(*)N=*)ncc(C(C2)=NOC3C2CCCCC3)c1NC(CC1)CCS1(=O)=O 0.000 description 8
- NMMAYZCPQHQNLP-UHFFFAOYSA-N C=NC1CCSCC1 Chemical compound C=NC1CCSCC1 NMMAYZCPQHQNLP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN550DE2007 | 2007-03-14 | ||
| IN550/DEL/2007 | 2007-03-14 | ||
| PCT/IB2008/050943 WO2008111010A1 (en) | 2007-03-14 | 2008-03-14 | Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010521451A JP2010521451A (ja) | 2010-06-24 |
| JP2010521451A5 true JP2010521451A5 (enExample) | 2014-08-14 |
| JP5671236B2 JP5671236B2 (ja) | 2015-02-18 |
Family
ID=39575541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009553263A Expired - Fee Related JP5671236B2 (ja) | 2007-03-14 | 2008-03-14 | ホスホジエステラーゼ阻害剤としてのピラゾロ（３，４−ｂ）ピリジン誘導体 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8420666B2 (enExample) |
| EP (1) | EP2124944B1 (enExample) |
| JP (1) | JP5671236B2 (enExample) |
| KR (1) | KR101568884B1 (enExample) |
| CN (2) | CN101801376A (enExample) |
| AP (1) | AP2453A (enExample) |
| AT (1) | ATE545417T1 (enExample) |
| AU (1) | AU2008224541B2 (enExample) |
| CA (1) | CA2680625C (enExample) |
| CY (1) | CY1112805T1 (enExample) |
| DK (1) | DK2124944T3 (enExample) |
| EA (1) | EA018670B9 (enExample) |
| ES (1) | ES2382715T3 (enExample) |
| HR (1) | HRP20120361T1 (enExample) |
| MX (1) | MX2009009793A (enExample) |
| NZ (1) | NZ579645A (enExample) |
| PL (1) | PL2124944T3 (enExample) |
| PT (1) | PT2124944E (enExample) |
| SI (1) | SI2124944T1 (enExample) |
| WO (1) | WO2008111010A1 (enExample) |
| ZA (1) | ZA200906418B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1934219A1 (en) * | 2005-09-16 | 2008-06-25 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| RU2008139599A (ru) * | 2006-03-07 | 2010-04-20 | Эррэй Биофарма Инк. (Us) | Гетеробициклические производные пиразола и способы их применения |
| JP2009539878A (ja) * | 2006-06-08 | 2009-11-19 | アレイ バイオファーマ、インコーポレイテッド | キノリン化合物および使用方法 |
| PL2057125T3 (pl) * | 2006-08-16 | 2011-09-30 | Hoffmann La Roche | Nienukleozydowe inhibitory odwrotnej transkryptazy |
| CA2735956A1 (en) * | 2008-09-19 | 2010-04-29 | Ranbaxy Laboratories Limited | Phosphodiestarase inhibitors |
| EP2848256B1 (en) | 2009-12-08 | 2018-11-14 | Vanderbilt University | Improved methods and compositions for vein harvest and autografting |
| US10034861B2 (en) | 2016-07-04 | 2018-07-31 | H. Lundbeck A/S | 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors |
| US10246462B2 (en) | 2016-09-09 | 2019-04-02 | Flx Bio, Inc. | Chemokine receptor modulators and uses thereof |
| JOP20190126A1 (ar) | 2016-12-22 | 2019-05-28 | H Lundbeck As | بيرازولو [3، 4-b] بيريدينات وإيميدازو [1، 5-b] بيريدازينات على هيئة مثبطات PDE1 |
| EA037544B1 (ru) * | 2017-04-04 | 2021-04-12 | Х. Лундбекк А/С | ПРИМЕНЕНИЕ 1H-ПИРАЗОЛО[4,3-b]ПИРИДИНОВ В КАЧЕСТВЕ ИНГИБИТОРОВ PDE1 |
| CN111465410B (zh) | 2017-12-14 | 2022-10-25 | H.隆德贝克有限公司 | 包括施用1h-吡唑并[4,3-b]吡啶的组合治疗 |
| AR113926A1 (es) | 2017-12-14 | 2020-07-01 | H Lundbeck As | Derivados de 1h-pirazolo[4,3-b]piridinas |
| TW201927784A (zh) | 2017-12-20 | 2019-07-16 | 丹麥商Ｈ 朗德貝克公司 | 作為pde1抑制劑之大環 |
| JP7194738B2 (ja) | 2017-12-20 | 2022-12-22 | ハー・ルンドベック・アクチエゼルスカベット | ＰＤＥ１阻害剤としてのピラゾロ［３，４－ｂ］ピリジン及びイミダゾ［１，５－ｂ］ピリダジン |
| US10766893B2 (en) | 2017-12-20 | 2020-09-08 | H. Lundbeck A/S | 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors |
| CN113200997B (zh) * | 2021-05-07 | 2023-10-03 | 上海合全医药有限公司 | 2,5-二氧杂-8-氮杂螺[3.5]壬烷及其盐的合成方法 |
Family Cites Families (95)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1047518A (en) | 1963-06-11 | 1966-11-02 | Glaxo Lab Ltd | 17ª-monoesters of 11,17,21-trihydroxy steroid compounds |
| NL128816C (enExample) | 1965-04-22 | |||
| GB1159490A (en) | 1966-02-09 | 1969-07-23 | Boots Pure Drug Co Ltd | Improvements in Acylated Steroids |
| GB1200886A (en) | 1966-09-23 | 1970-08-05 | Allen & Hanburys Ltd | Phenylaminoethanol derivatives |
| US3937838A (en) | 1966-10-19 | 1976-02-10 | Aktiebolaget Draco | Orally active bronchospasmolytic compounds and their preparation |
| US3639434A (en) | 1967-02-02 | 1972-02-01 | Boots Pure Drug Co Ltd | 17-acyloxysteroids and their manufacture |
| US3780177A (en) * | 1967-06-16 | 1973-12-18 | Warner Lambert Co | 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use |
| CH513845A (de) * | 1967-11-17 | 1971-10-15 | Ciba Geigy Ag | Verfahren zur Herstellung neuer Halogenpregnadiene |
| GB1253831A (en) | 1968-01-19 | 1971-11-17 | Glaxo Lab Ltd | 9alpha,21-DIHALOPREGNANE COMPOUNDS |
| US3700681A (en) * | 1971-02-16 | 1972-10-24 | Pfizer | 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines |
| US3947478A (en) * | 1972-01-12 | 1976-03-30 | Akzona Incorporated | Alkylated 3,20-diketo-Δ4 -steroids of the pregnane series |
| US3994974A (en) * | 1972-02-05 | 1976-11-30 | Yamanouchi Pharmaceutical Co., Ltd. | α-Aminomethylbenzyl alcohol derivatives |
| SE378109B (enExample) * | 1972-05-19 | 1975-08-18 | Bofors Ab | |
| SE378110B (enExample) | 1972-05-19 | 1975-08-18 | Bofors Ab | |
| US3992534A (en) | 1972-05-19 | 1976-11-16 | Ab Bofors | Compositions and method of treating with component B of stereoisomeric mixtures of 2'-unsymmetrical 16,17-methylenedioxy steriods |
| US4098804A (en) | 1973-05-30 | 1978-07-04 | Jouveinal S.A. | Esters of 21-thiol prednisone and prednisolone |
| FR2231374B1 (enExample) * | 1973-05-30 | 1976-10-22 | Jouveinal Sa | |
| US4011258A (en) | 1973-06-21 | 1977-03-08 | Aktiebolaget Draco | Orally active bronchospasmolytic compounds |
| ZA744259B (en) * | 1973-08-17 | 1975-06-25 | American Cyanamid Co | Topical steroid |
| US3980778A (en) | 1973-10-25 | 1976-09-14 | The Upjohn Company | Anti-inflammatory steroid |
| NL7502252A (nl) * | 1974-02-27 | 1975-08-29 | Pierrel Spa | Werkwijze voor het bereiden van een geneesmid- del met anti-inflammatoire werking, gevormd ge- neesmiddel verkregen volgens deze werkwijze alsmede werkwijze voor het bereiden van in het geneesmiddel gebruikte nieuwe steroiden. |
| DE2655570A1 (de) | 1975-12-12 | 1977-06-16 | Ciba Geigy Ag | Neue polyhalogensteroide und verfahren zu ihrer herstellung |
| US4076708A (en) | 1976-12-22 | 1978-02-28 | Schering Corporation | Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby |
| US4124707A (en) | 1976-12-22 | 1978-11-07 | Schering Corporation | 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor |
| US4081541A (en) | 1976-12-28 | 1978-03-28 | Rorer Italiana S.P.A. | Steroid derivatives |
| DE2735110A1 (de) | 1977-08-04 | 1979-02-15 | Hoechst Ag | Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung |
| JPS6040439B2 (ja) | 1978-03-29 | 1985-09-11 | 大正製薬株式会社 | ヒドロコルチゾン誘導体 |
| CA1201114A (en) | 1980-02-15 | 1986-02-25 | Gordon H. Phillipps | Androstane carbothioates |
| CY1273A (en) | 1980-07-09 | 1985-03-08 | Draco Ab | 1-(dihydroxyphenyl)-2-amino-ethanol derivatives;preparation,compositions and intermediates |
| US4298604B1 (en) * | 1980-10-06 | 1998-12-22 | Schering Corp | Clotrimazole-betamethasone dipropionate combination |
| DE3260474D1 (en) | 1981-02-02 | 1984-09-06 | Schering Corp | Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them |
| DE3133081A1 (de) | 1981-08-18 | 1983-03-10 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung |
| US4472392A (en) | 1983-01-21 | 1984-09-18 | The Upjohn Company | Sulfonate containing ester prodrugs of corticosteroids |
| ZW6584A1 (en) * | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
| CA1240708A (en) | 1983-11-15 | 1988-08-16 | Johannes K. Minderhoud | Process for the preparation of hydrocarbons |
| CA1261835A (en) * | 1984-08-20 | 1989-09-26 | Masaaki Toda | (fused) benz(thio)amides |
| GB8425104D0 (en) * | 1984-10-04 | 1984-11-07 | Ici America Inc | Amide derivatives |
| GB8607294D0 (en) * | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
| US4826868A (en) * | 1986-05-29 | 1989-05-02 | Ortho Pharmaceutical Corporation | 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use |
| US4873259A (en) * | 1987-06-10 | 1989-10-10 | Abbott Laboratories | Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
| CA1326662C (en) | 1988-03-09 | 1994-02-01 | Yutaka Mizushima | 11.beta.,17.,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-[(e,e)-3,7,11-trimethyl-2,6,10-dodecatrienoate] |
| US5278156A (en) | 1988-03-09 | 1994-01-11 | Kuraray Co., Ltd. | 11-beta, 17-alpha, 21-trihydroxy-1, 4-pregnadiene-3, 20 21-[(E-E)-3,7, 11-trimethyl-2,6,10-dodecatrienoate] |
| NZ234883A (en) | 1989-08-22 | 1995-01-27 | Merck Frosst Canada Inc | Quinolin-2-ylmethoxy indole derivatives, preparation and pharmaceutical compositions thereof |
| GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
| PL165803B1 (pl) | 1990-09-10 | 1995-02-28 | Schering Corp | Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL |
| US5565473A (en) * | 1990-10-12 | 1996-10-15 | Merck Frosst Canada, Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| US6127353A (en) * | 1991-09-06 | 2000-10-03 | Schering Corporation | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| EP0542355A1 (en) | 1991-11-15 | 1993-05-19 | Merck Frosst Canada Inc. | Amorphous (Quinolin-2-ylmethoxy)indoles as leukotriene antagonists |
| US5254541A (en) | 1991-11-15 | 1993-10-19 | Merck Frosst Canada, Inc. | (Quinolin-2-ylmethoxy)indole/cyclodextrin complex |
| US5837699A (en) | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
| TW438585B (en) | 1995-02-06 | 2001-06-07 | Astra Ab | Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections |
| WO1997048697A1 (en) | 1996-06-19 | 1997-12-24 | Rhone-Poulenc Rorer Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| HUP9903009A3 (en) | 1996-06-25 | 2002-01-28 | Pfizer | Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| US5976573A (en) * | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
| NZ334213A (en) | 1996-09-04 | 2000-08-25 | Pfizer | Indazole derivatives as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) for treating asthma, arthritis, bronchitis, CNS disorders |
| ZA985247B (en) | 1997-06-19 | 1999-12-17 | Du Pont Merck Pharma | Guanidine mimics as factor Xa inhibitors. |
| US6339099B1 (en) | 1997-06-20 | 2002-01-15 | Dupont Pharmaceuticals Company | Guanidine mimics as factor Xa inhibitors |
| IL135105A0 (en) * | 1997-10-06 | 2001-05-20 | American Cyanamid Co | The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| NZ503995A (en) | 1997-11-04 | 2003-02-28 | Pfizer Prod Inc | Indazole compounds, and pharmaceutical compositions and uses thereof, based on indazole bioisostere replacement of catechol in PDE4 inhibitors |
| SK6252000A3 (en) | 1997-11-04 | 2001-11-06 | Pfizer Prod Inc | Indazole bioisostere replacement of catechol in therapeutically active compounds |
| JP2000198734A (ja) | 1998-12-30 | 2000-07-18 | Pfizer Inc | 胃運動性減弱および関連疾患の治療のための運動性増強薬 |
| ES2197092T3 (es) | 1999-04-02 | 2004-01-01 | Bristol-Myers Squibb Pharma Company | Sulfonil arilos como inhibidores del factor xa. |
| US20030176421A1 (en) * | 1999-12-30 | 2003-09-18 | Watson John W. | Prokinetic agents for treating gastric hypomotility and related disorders |
| DE10050994A1 (de) | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
| DE10050995A1 (de) | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| EP1345935A2 (en) | 2000-12-21 | 2003-09-24 | Warner-Lambert Company LLC | Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists |
| WO2002051837A2 (en) | 2000-12-22 | 2002-07-04 | Wyeth | Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| HUP0400682A2 (hu) | 2000-12-22 | 2004-06-28 | Wyeth | 5-Hidroxitriptamin-6-ligandumként használható heterociklilalkilindol- és -azaindol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények |
| MXPA02002749A (es) | 2001-03-27 | 2002-10-28 | Warner Lambert Co | Derivados de ciclohexilamina como antagonistas del subtipo selectivo del n-metil-d-aspartato. |
| WO2002088079A2 (en) * | 2001-05-01 | 2002-11-07 | Bristol-Myers Squibb Company | Dual inhibitors of pde 7 and pde 4 |
| TW200302225A (en) | 2001-12-04 | 2003-08-01 | Bristol Myers Squibb Co | Substituted amino methyl factor Xa inhibitors |
| TW200406385A (en) * | 2002-05-31 | 2004-05-01 | Eisai Co Ltd | Pyrazole compound and pharmaceutical composition containing the same |
| GB0230045D0 (en) | 2002-12-23 | 2003-01-29 | Glaxo Group Ltd | Compounds |
| WO2004037814A1 (en) | 2002-10-25 | 2004-05-06 | Vertex Pharmaceuticals Incorporated | Indazolinone compositions useful as kinase inhibitors |
| IS7839A (is) * | 2002-11-22 | 2004-05-23 | Merck Frosst Canada Ltd. | 4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar |
| CA2518398A1 (en) | 2003-03-10 | 2004-09-23 | Schering Corporation | Heterocyclic kinase inhibitors: methods of use and synthesis |
| DE10318611A1 (de) * | 2003-04-24 | 2004-11-11 | Elbion Ag | 4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika |
| AU2004259738B2 (en) | 2003-07-17 | 2011-11-17 | Plexxikon, Inc. | PPAR active compounds |
| RU2387646C2 (ru) * | 2003-08-29 | 2010-04-27 | Рэнбакси Лабораториз Лимитед | Ингибиторы фосфодиэстеразы типа-iv |
| US7396833B2 (en) | 2003-12-22 | 2008-07-08 | Memory Pharmaceuticals Corporation | Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| CA2567977A1 (en) | 2004-04-22 | 2006-01-05 | Memory Pharmaceutical Corporation | Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| ATE415400T1 (de) | 2004-07-05 | 2008-12-15 | Astellas Pharma Inc | Pyrazolopyridinderivate |
| WO2006016237A2 (en) | 2004-08-04 | 2006-02-16 | Ranbaxy Laboratories Limited | Heterocyclic derivatives as anti-inflammatory agents |
| WO2006021848A1 (en) | 2004-08-27 | 2006-03-02 | Ranbaxy Laboratories Limited | Anti-inflammatory agents |
| WO2006050076A1 (en) | 2004-10-29 | 2006-05-11 | Janssen Pharmaceutica, N.V. | Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders |
| NZ555566A (en) | 2004-11-22 | 2009-12-24 | Vertex Pharma | Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
| US20090131430A1 (en) | 2004-11-23 | 2009-05-21 | Palle Venkata P | Pyrido'2,3-dipyrimidines as anti-inflammatory agents |
| JP2008521829A (ja) | 2004-11-30 | 2008-06-26 | プレキシコン，インコーポレーテッド | Ｐｐａｒ活性化合物 |
| AU2005311826A1 (en) | 2004-11-30 | 2006-06-08 | Plexxikon, Inc. | Indole derivatives for use as PPAR active compounds |
| US20090036472A1 (en) | 2005-02-02 | 2009-02-05 | Palle Venkata P | Azabicyclo derivatives as anti-inflammatory agents |
| MX2007010721A (es) | 2005-03-01 | 2007-11-13 | Pfizer Ltd | Nuevo uso de inhibidores de fosfodiesterasa 7 para el tratamiento de dolor neuropatico. |
| WO2006117657A1 (en) | 2005-05-03 | 2006-11-09 | Ranbaxy Laboratories Limited | Triazolone derivatives as anti-inflammatory agents |
| US20100022571A1 (en) * | 2005-09-16 | 2010-01-28 | Palle Venkata P | Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors |
| EP1940836A1 (en) * | 2005-09-29 | 2008-07-09 | Glaxo Group Limited | Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor |
| US20120004201A1 (en) * | 2008-09-19 | 2012-01-05 | Sonali Rudra | Phosphodiestarase inhibitors |
-
2008
- 2008-03-14 EP EP08737621A patent/EP2124944B1/en not_active Not-in-force
- 2008-03-14 AP AP2009004977A patent/AP2453A/xx active
- 2008-03-14 AT AT08737621T patent/ATE545417T1/de active
- 2008-03-14 CA CA2680625A patent/CA2680625C/en not_active Expired - Fee Related
- 2008-03-14 NZ NZ579645A patent/NZ579645A/en not_active IP Right Cessation
- 2008-03-14 PT PT08737621T patent/PT2124944E/pt unknown
- 2008-03-14 WO PCT/IB2008/050943 patent/WO2008111010A1/en not_active Ceased
- 2008-03-14 EA EA200970852A patent/EA018670B9/ru not_active IP Right Cessation
- 2008-03-14 DK DK08737621.6T patent/DK2124944T3/da active
- 2008-03-14 KR KR1020097021120A patent/KR101568884B1/ko not_active Expired - Fee Related
- 2008-03-14 AU AU2008224541A patent/AU2008224541B2/en not_active Ceased
- 2008-03-14 SI SI200830590T patent/SI2124944T1/sl unknown
- 2008-03-14 ES ES08737621T patent/ES2382715T3/es active Active
- 2008-03-14 US US12/531,043 patent/US8420666B2/en not_active Expired - Fee Related
- 2008-03-14 HR HRP20120361AT patent/HRP20120361T1/hr unknown
- 2008-03-14 PL PL08737621T patent/PL2124944T3/pl unknown
- 2008-03-14 MX MX2009009793A patent/MX2009009793A/es active IP Right Grant
- 2008-03-14 JP JP2009553263A patent/JP5671236B2/ja not_active Expired - Fee Related
- 2008-03-14 CN CN200880014410A patent/CN101801376A/zh active Pending
- 2008-03-14 CN CN201310379773.0A patent/CN103497185A/zh active Pending
-
2009
- 2009-09-15 ZA ZA200906418A patent/ZA200906418B/xx unknown
-
2012
- 2012-04-26 CY CY20121100403T patent/CY1112805T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010521451A5 (enExample) | ||
| HRP20120361T1 (hr) | DERIVATI PIRAZOLO[3,4-b]PIRIDINA KAO INHIBITORI FOSFODIESTERAZE | |
| DK1966162T3 (en) | pyrimidine | |
| CA2672373C (en) | Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases | |
| ES2346674T3 (es) | Compuestos heteroaromaticos de quinolina y su uso como inhibidores de pde10. | |
| CA2579087C (en) | Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof | |
| JP2012517971A5 (enExample) | ||
| WO2001027104A1 (en) | Substituted imidazolidinone derivatives | |
| AU2004315876A1 (en) | Pyrazolopyridines and analogs thereof | |
| AU2006232188A1 (en) | Pyrazolopyridines and analogs thereof | |
| BG64052B1 (bg) | Заместени индазолови производни и тяхното използване като инхибитори на фосфодиестераза (рdе) тип iv и на произвеждането на туморен некрозен фактор (tnf) | |
| AU2008215490A2 (en) | Fused ring compounds as partial agonists of PPAR-gamma | |
| BG64447B1 (en) | Indazole derivatives, pharmaceutical compositions and application thereof | |
| AU7787300A (en) | Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase | |
| WO2004094420A1 (en) | Condensed n-heterocyclic compounds and their use as crf receptor antagonists | |
| EP0378255A2 (en) | 2-Aminopyrimidinone derivatives | |
| TWI643850B (zh) | 作為呼吸道融合病毒之抗病毒劑的新穎經雜環取代之１，３－二氫－２ｈ－苯并咪唑－２－酮衍生物 | |
| CA2208792C (en) | Substituted indazole derivatives | |
| HRP920155A2 (en) | IMIDAZO (2,1-b) BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD FOR THE USE THEREOF | |
| WO2005073222A1 (en) | 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-ht4 receptor agonistic activity | |
| KR20120088759A (ko) | 카세인 키나제 억제제로서의 이미다졸 유도체 | |
| JP2024512501A (ja) | インダゾール系化合物及び関連使用方法 | |
| WO2004069828A1 (ja) | ピペリジン化合物およびその医薬用途 | |
| JP2008514713A (ja) | ４，５−ジヒドロ−ピラゾロ［３，４−ｃ］ピリド−２−オン類の製造 | |
| WO2008029882A1 (en) | 2-alkyl-6-(pyrazolopyridin-4-yl)pyridazinone derivative, addition salt thereof, and pde inhibitor comprising the derivative or the salt as active ingredient |